Moncef Mohamed Slaoui [1] (English: / ˈ m ɒ n s ɪ f ˈ s l aʊ. i /; French: [mɔ̃sɛf slawi]; Moroccan Arabic: منصف السلاوي, IPA: [ˈmonsˤəf ˈsːlæwi]; born July 22, 1959) is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.

Mar 24, 2021 · Moncef Slaoui, a former head of Operation Warp Speed, who spearheaded COVID-19 vaccine development in the USA, was fired by GSK for harassing an employee.

Mar 24, 2021 · Moncef Slaoui, the former head of Operation Warp Speed, was fired from a biotech company after sexual misconduct allegations.

Mar 25, 2021 · Moncef Slaoui, the former scientific director of COVID-19 vaccine development at Operation Warp Speed during the Trump administration, has been fired from a joint venture of GlaxoSmithKline...

In 2015, Mosquirix, the world's first vaccine for the dreaded disease, was approved by the European Medical Agency. “I cried — it’s very personal,” Slaoui recalled on hearing the news of the vaccine’s approval after his decades-long quest. He retired from GSK in 2017.

6 days ago · "Dr. Moncef Slaoui has a long-proven track record in the pharmaceutical and biotechnology industry, and we are delighted to have him as our Chair Designate," said Joseph Payne, President & Chief ...

Mar 24, 2021 · Moncef Slaoui, who led former President Donald Trump’s effort to produce Covid-19 vaccines, was fired from a company board over sexual harassment allegations.

6 days ago · Dr. Moncef Slaoui was most recently the Chief Scientific Advisor to Operation Warp Speed. Under his leadership the operation enabled the fastest ever development, manufacturing, and approval of ...

Mar 24, 2021 · Moncef Slaoui, who helped lead Operation Warp Speed under the Trump administration, was removed from a medical device startup's board over allegations of sexual harassment.

Dr. Slaoui was most recently the Chief Scientific Advisor to Operation Warp Speed. Under his leadership the operation enabled the fastest ever development, manufacturing, and approval of multiple COVID-19 vaccines in less than 11 months after …